Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Spartanburg, SC
NPI: 1013128792Primary Practice Location
SPARTANBURG MEDICAL CENTER
101 E Wood St, Spartanburg, SC
Primary Employer
Spartanburg Medical Center
spartanburgregional.com
HQ Phone
Get M.D. Vikas's Phone Numberphone_androidMobile
Get M.D. Vikas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMS State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 168 | 360 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 153 | 289 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 111 | 155 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 18 |
Hematuria--a rare presentation of Hodgkin lymphoma.
Authors: Stephanie Elkins
Journal: Clin Adv Hematol Oncol
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic.
Authors: Vivek Subbiah, Daniel Karp, Funda Meric, Sarina Piha-Paul, Neeta Somaiah
Publication Date: 2018-01-04
Cyclosporine dependent pure red cell aplasia: a case presentation.
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, OTHER: Patient Observation, PROCEDURE: Echocardiography Test
Lead Sponsor: ImmunityBio, Inc.
Intervention / Treatment: DRUG: N-803 + Pembrolizumab, DRUG: N-803 + Nivolumab, DRUG: N-803 + Atezolizumab, DRUG: N-803 + Avelumab, DRUG: N-803 + Durvalumab, DRUG: N-803 + Pembrolizumab + PD-L1 t-haNK, DRUG: N-803 + Nivolumab + PD-L1 t-haNK, DRUG: N-803 + Atezolizumab + PD-L1 t-haNK, DRUG: N-803 + Avelumab + PD-L1 t-haNK, DRUG: N-803 + Durvalumab + PD-L1 t-haNK, DRUG: N-803 + Docetaxel + Pembrolizumab, DRUG: N-803 + Docetaxel + Nivolumab
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Leucovorin, OTHER: Patient Observation, DRUG: Leucovorin Calcium
